BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16282776)

  • 1. First trimester ultrasound screening for fetal aneuploidy and middle cerebral artery Doppler assessment for fetal alloimmunization.
    Biggio JR
    Curr Opin Pediatr; 2005 Dec; 17(6):713-9. PubMed ID: 16282776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive diagnosis of fetal anemia due to maternal red-cell alloimmunization.
    Ahmed B; Ghaffari Z; Ismail RS; Saleh N
    Saudi Med J; 2005 Feb; 26(2):256-9. PubMed ID: 15770301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal anemia: new technologies.
    Segata M; Mari G
    Curr Opin Obstet Gynecol; 2004 Apr; 16(2):153-8. PubMed ID: 15017345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler ultrasonography versus amniocentesis to predict fetal anemia.
    Oepkes D; Seaward PG; Vandenbussche FP; Windrim R; Kingdom J; Beyene J; Kanhai HH; Ohlsson A; Ryan G;
    N Engl J Med; 2006 Jul; 355(2):156-64. PubMed ID: 16837679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.
    Mari G; Deter RL; Carpenter RL; Rahman F; Zimmerman R; Moise KJ; Dorman KF; Ludomirsky A; Gonzalez R; Gomez R; Oz U; Detti L; Copel JA; Bahado-Singh R; Berry S; Martinez-Poyer J; Blackwell SC
    N Engl J Med; 2000 Jan; 342(1):9-14. PubMed ID: 10620643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic screening for fetal aneuploidy: first trimester.
    Souter VL; Nyberg DA
    J Ultrasound Med; 2001 Jul; 20(7):775-90. PubMed ID: 11444737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional management of maternal red cell alloimmunization compared with management by Doppler assessment of middle cerebral artery peak systolic velocity.
    Pereira L; Jenkins TM; Berghella V
    Am J Obstet Gynecol; 2003 Oct; 189(4):1002-6. PubMed ID: 14586344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.
    Nemescu D; Bratie A; Mihaila A; Navolan D; Tanase A
    Ginekol Pol; 2018; 89(4):205-10. PubMed ID: 29781076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doppler blood flow velocity in the evaluation of fetal anemia].
    L'ubuský M; Procházka M; Santavý J; Machac S; Mícková I
    Ceska Gynekol; 2004 Jul; 69(4):316-20. PubMed ID: 15369254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
    Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
    Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
    Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of peak systolic velocity of the middle cerebral artery in the management of fetal anemia due to fetomaternal erythrocyte alloimmunization].
    Carbonne B; Castaigne-Meary V; Cynober E; Gougeul-Tesnière V; Cortey A; Soulié JC; Larsen M; Méraud B; Ansquer Y; Milliez J; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):163-9. PubMed ID: 18006243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.